Bala Cynwyd, PA – Layla’s Legacy Foundation (LLF) is committed to fighting for childhood cancer research and better, less toxic treatments for children, and has donated $50,000 to Alex’s Lemonade Stand Foundation (ALSF). Together, the two foundations will jointly fund innovative pediatric cancer research, including research that can advance the field of medulloblastoma research.

The funding from Layla’s Legacy Foundation will be used to advance the following grant:
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade
Dr. Catherine Flores, PhD
University of Florida

Since its establishment in 2018, Layla’s Legacy Foundation has focused its efforts on funding innovative research and supporting families impacted by the disease. Layla’s Legacy also works closely with social workers at hospitals to understand specific financial needs they have. Sara Stamp, Layla’s mom and executive director of Layla’s Legacy, is also happy to be working with ALSF. “Layla’s Legacy Foundation is excited to continue to support Dr. Flores’ research. In 2018, LLF donated $50,000 to her study and we were able to double our efforts in 2019 thanks to Alex’s Lemonade Stand Foundation. We believe Dr. Flores’ research is critical in understanding the genetic makeup of the deadliest forms of medulloblastoma and those that currently have no viable treatments.”

Jay Scott, Alex’s dad and co-executive director of ALSF is also thrilled about the partnership and chance to work together for a common goal. “We are excited about the opportunity to partner with Layla’s Legacy Foundation. They share the same knowledge and passion for curing cancer as ALSF. Combing our resources will only make us stronger.”